STM · DEEP VALUE BRIEFING

STMicroelectronics N.V. (STM)

published May 10, 2026 · price now $57.33 · market cap $52.9B

WATCH · low confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

Executive Briefing

Verdict: WATCH

STM may be near a cyclical earnings trough, and its exposure to automotive, industrial, power semis, and silicon carbide gives it real long-term relevance. But from a Buffett-style risk lens, the key issue is not whether chips matter — it is whether this business can earn durable high returns and whether the stock offers a margin of safety today. Right now, the answer is unclear.

Current returns are extremely weak (ROIC 0.8%, ROE 0.9%), revenue and earnings are falling (-11.1% revenue, -89.3% net income), and the valuation support presented is poor ($10.85 value estimate vs. $59.17 stock price). That does not rule out a rebound, but it does mean the investor is being asked to pay for recovery before recovery is proven. For a long-term value investor, that is a risk-control problem, not an opportunity by default.

Key Arguments from the Debate

1. Risky Analyst’s strongest point

The bull case is that STM is being judged on trough numbers. In semiconductors, low current profits can make standard valuation metrics misleading. If margins, utilization, and demand recover, the stock could rerate before the reported numbers look healthy. STM’s positioning in automotive electrification, industrial automation, power management, and silicon carbide gives the recovery thesis strategic credibility.

2. Safe Analyst’s strongest point

The bear case is more relevant for a Buffett-style investor: weak current economics plus weak valuation support is a dangerous combination. Near-zero returns on capital are not just “ugly optics”; they show the business is currently not demonstrating moat-like economics. And if the stock already trades far above conservative value estimates, the margin of safety is missing.

3. Neutral Analyst’s strongest point

Both extremes overreach. It is reasonable to avoid buying aggressively now, but also reasonable to prepare for a staged entry if the business begins to prove recovery. The right posture is active WATCH, not passive indecision and not full commitment.

Rationale

The investor’s original plan is already directionally correct, and the analyst debate mostly reinforces it.

The strongest bull argument is that STM is being judged at what may be a cyclical trough rather than on normalized earning power. There is real logic to that. Automotive, industrial, power semis, and silicon carbide are better end markets than consumer gadgets, and they benefit from long-duration trends like vehicle electrification, automation, and energy efficiency. The bull is also right that semiconductor P/E ratios become nearly meaningless at earnings bottoms, and that design wins in automotive and embedded systems can create stickier relationships than the market sometimes credits.

The strongest bear argument is simpler and, to me, more Buffett-relevant: even if the long-term markets are attractive, STM does not currently exhibit the kind of moat, return profile, predictability, or valuation support that a true value investor should demand. ROE around 0.9%, ROIC around 0.8%, revenue down 11.1%, and net income down 89.3% are not just ugly optics. They show how exposed the business is to cyclical swings and how hard it is to confidently underwrite normalized economics. And the valuation evidence in the handoff is a serious problem: a Damodaran average value of $10.85 against a $59.17 stock price leaves no obvious margin of safety.

The Risky Analyst is correct that waiting for perfect confirmation can mean missing the first leg of a cyclical rebound. But Buffett-style investing is not about capturing the first leg. It is about avoiding situations where too much of the thesis depends on hopeful normalization. Here, the business may recover, but the available evidence does not yet show durable excess returns or a clearly discounted price.

The Safe Analyst is right to emphasize capital preservation, but the Neutral Analyst improves the process by distinguishing between “do not buy now” and “ignore completely.” STM is not obviously broken. It is just not clearly cheap, not clearly superior, and not clearly predictable.

Refinement of the Investor’s Plan

Your original plan should remain WATCH, but sharpened into a more disciplined conditional framework.

What remains right in the original plan

  • The business may recover.
  • The end markets are real and strategically attractive.
  • Current evidence is still insufficient for a Buffett-style endorsement.
  • Margin of safety is not visible.
  • Quality should be judged by returns on capital and free cash flow durability, not by narrative strength.

What should be adjusted after the debate

  1. Treat trough earnings as a possible explanation, not a conclusion.

Do not assume current weakness is temporary just because semis are cyclical.

  1. Do not rely on P/E at all here.

At 369.81, it tells you more about depressed earnings than real valuation.

  1. Be skeptical of the FCF improvement.

FCF growth of 75.9% is encouraging, but with net income down 89.3%, it may reflect working-capital effects rather than durable earnings strength.

  1. Separate secular demand from shareholder economics.

“Chips in cars and factories will grow” does not automatically mean STM will earn high incremental returns.

  1. Use staged conviction, not binary conviction.

If evidence improves, this could move from WATCH toward ADVOCATE later. But today the burden of proof is still on the company.

What to Monitor Over the Next 1–4 Quarters

Keep the checklist concrete:

  • Gross margin and operating margin: Need clear improvement from the current 33.9% gross margin.
  • Revenue trend by segment: Especially automotive and industrial. Look for contraction narrowing or turning positive.
  • ROIC and ROE: These must move meaningfully off near-zero levels.
  • Silicon carbide economics: Is it scaling profitably or just consuming capital?
  • Inventory and utilization: Watch for real demand recovery, not just restocking.
  • Capex discipline and FCF quality: FCF should be supported by operations, not temporary working-capital release.
  • Customer stickiness: Any evidence of stronger switching costs, embedded wins, or pricing power matters.

Learning from Past Mistakes

The biggest recurring mistake in cyclical and thematic industries is confusing a good story with a good investment. Secular tailwinds, AI adjacency, EV content growth, and industrial automation are all attractive narratives. But past misjudgments often come from giving too much credit to those themes and too little weight to present returns, capital intensity, and valuation.

Another common mistake is buying because a stock “used to be better” or “should normalize,” without demanding proof that the economics can recover. Buffett-style risk management avoids that by asking:

  • Is the business predictably good?
  • Is the balance between price and intrinsic value favorable?
  • Are returns on capital strong enough to support confidence?

STM does not clear those bars yet.

Final Stance

WATCH

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2025), updated Oct 4, 2026; the market price was $57.33. Values are estimates, not predictions.

Two-stage FCFF (Damodaran)

Projects revenue, operating margin and reinvestment, then discounts free cash flow to the firm at the weighted cost of capital.

Value per share: $1.86 / $16.22 / $29.64 (conservative / base / optimistic)

Starting Damodaran FCFF$153M
Growth: conservative / base / optimistic (2011–2025)-8.0% / 1.4% / 13.6%
Projection10 years
Risk-free rate5.28%
Equity risk premium4.15%
Beta1.00
Cost of equity9.43%
After-tax cost of debt2.25%
Equity weight96%
WACC (discount rate)9.13%
Target operating margin (base)12.0%
High-growth stage5 years
Terminal growth2.5%
Shares outstanding923M

This briefing is from May 10, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

Run a fresh briefing →Watch the video briefingGet the iPhone app

The Monday letter

One email a week: what great value investors bought and sold, and what we make of it.

Send me the DeepValues Monday letter, one email a week. I can unsubscribe at any time. Information only, not investment advice. Privacy